AI assistant
Sending…
MIMEDX GROUP, INC. — Director's Dealing 2014
Feb 27, 2014
32206_dirs_2014-02-27_254d280e-c7dc-45da-887d-487a5f8a4cbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2014-02-25
Reporting Person: Senken Michael J. (Director, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-25 | Restricted Common Stock | A | 15976 | $7.24 | Acquired | 99226 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-25 | Stock Option | $7.24 | A | 49607 | Acquired | 2024-02-24 | Common Stock (49607) | Direct |
Footnotes
F1: The restricted shares vest over three years in equal 1/3 installments on the 1st, 2nd, and 3rd anniversary dates of the grant.
F2: 50,000 of these shares are Common Stock. 49,226 of these shares are Restricted and vest in equal installments over the first three anniversary dates of the grants.
F3: The stock options vest over three years in equal 1/3 installments on the 1st, 2nd and 3rd anniversary dates of the grant.
More from MIMEDX GROUP, INC.
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 16
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Nov 10